The company reports adjusted earnings of $2.77 a share for the second quarter, beating analysts’ estimates of $2.68.

Several minor U.S. trading partners are about to get hit by levies, President Donald Trump told reporters late Tuesday.

Lilly, Johnson & Johnson, AbbVie, Pfizer and more pharma stocks shrug even amid Trump's fresh pharma tariff threats.

Shares of the auto maker dropped after the company disclosed a pricey recall for potentially defective fuel injectors.

Mergers and acquisitions among registered investment advisors continue their brisk pace, with the first half of 2025 setting ...

Kosovare Asllani said Wednesday that Sweden should be getting more attention for their performances at the Women's Euro 2025 ...

Germany's Florian Wellbrock won the men's open water 10km at the World Aquatics Championships in Singapore on Wednesday, ...

Leo XIV has not long been pope, yet the American head of the Catholic Church already receives 100 kilogrammes of letters a ...

U.S. Businesses in China Are Worried: Survey. Market Share Is Under Pressure. While U.S.-China tensions may have reached a ...

With its fiscal fourth-quarter earnings just two weeks away, Microsoft is on track for another round of strong results, ...

HPE appoints longtime tech executive Robert M. Calderoni to the board as part of its agreement with Elliott Investment ...

The Fed is self-funding and doesn’t need outside approval for building projects, according to the law that created the ...